ImmunoGen (IMGN) Stock Forecast for 2023 – 2026. Sell or Buy?
Updated: December 3, 2023 (08:16)Sector: Healthcare
The share price of ImmunoGen, Inc. (IMGN) now
50/200 Day Moving Average: $15.08 / $12.55
This figure corresponds to the Average Price over the previous 50/200 days. For ImmunoGen stocks, the 50-day moving average is the support level today.
For ImmunoGen stocks, the 200-day moving average is the support level today.
Are you interested in ImmunoGen, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the ImmunoGen stock price in 2023, 2024, 2025, 2026, 2027. How much will one ImmunoGen share be worth in 2023 - 2027?
When should I take profit in ImmunoGen stock? When should I record a loss on ImmunoGen stock? What are analysts' forecasts for ImmunoGen stock? What is the future of ImmunoGen stock? We forecast ImmunoGen stock performance using neural networks based on historical data on ImmunoGen stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
ImmunoGen stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for ImmunoGen shares. This happens once a day.
Historical and forecast chart of ImmunoGen stock
The chart below shows the historical price of ImmunoGen stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the ImmunoGen stock price can be found in the table below.
Long-term forecasts by years.
ImmunoGen, Inc., a clinical-stage biotechnology company, is developing antibody-drug conjugate (ADC) therapies for cancer. Its candidate products include mirvetuximab soravtansine, an alpha-folate receptor-targeted ADC that is in phase III clinical trials for the treatment of platinum-resistant ovarian cancer; and IMGN632, an ADC targeting CD123, which is in phase I clinical trials for the treatment of AML and blast plasmacytoid dendritic cell neoplasms.
ImmunoGen daily forecast for a month
ImmunoGen Daily Price Targets
ImmunoGen Stock Forecast 12-05-2023.
Forecast target price for 12-05-2023: $29.88.
Positive dynamics for ImmunoGen shares will prevail with possible volatility of 1.951%.
Pessimistic target level: 29.70
Optimistic target level: 30.29
ImmunoGen Stock Forecast 12-06-2023.
Forecast target price for 12-06-2023: $29.76.
Negative dynamics for ImmunoGen shares will prevail with possible volatility of 2.462%.
Pessimistic target level: 29.55
Optimistic target level: 30.30
ImmunoGen Stock Forecast 12-07-2023.
Forecast target price for 12-07-2023: $29.13.
Negative dynamics for ImmunoGen shares will prevail with possible volatility of 2.887%.
Pessimistic target level: 28.63
Optimistic target level: 29.48
ImmunoGen Stock Forecast 12-08-2023.
Forecast target price for 12-08-2023: $28.97.
Negative dynamics for ImmunoGen shares will prevail with possible volatility of 3.027%.
Pessimistic target level: 28.60
Optimistic target level: 29.49
ImmunoGen Stock Forecast 12-09-2023.
Forecast target price for 12-09-2023: $29.48.
Positive dynamics for ImmunoGen shares will prevail with possible volatility of 2.084%.
Pessimistic target level: 29.00
Optimistic target level: 29.61
ImmunoGen Stock Forecast 12-10-2023.
Forecast target price for 12-10-2023: $30.03.
Positive dynamics for ImmunoGen shares will prevail with possible volatility of 2.733%.
Pessimistic target level: 29.50
Optimistic target level: 30.32
IMGN (IMGN) Monthly Stock Prediction for 2023
ImmunoGen forecast for this year
ImmunoGen Stock Prediction for Dec 2023
An downtrend is forecast for this month with an optimal target price of $18.0507. Pessimistic: $17.29. Optimistic: $19.11
ImmunoGen (IMGN) Monthly Stock Prediction for 2024
ImmunoGen (IMGN) Monthly Stock Prediction for 2025
ImmunoGen (IMGN) Monthly Stock Prediction for 2026
ImmunoGen (IMGN) Monthly Stock Prediction for 2027
ImmunoGen information and performance
830 WINTER ST, WALTHAM, MA, US
Market capitalization of the ImmunoGen, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of IMGN shares in the company outstanding by the market price of one share.
EBITDA of ImmunoGen is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.